People

Douglas Thomson

kineticos.comlinkedin.com

Douglas Thomson is published by Kineticos Life Sciences as Venture and Operating Partner. Douglas Thomson is Chief Executive Officer and co-founder at Pneumagen a clinical stage infectious disease business. Prior to co-founding Pneumagen, he led executive teams generating rapid value creation at companies such as GT Biologics a part of 4D Pharma. His background is in infectious disease vaccine research and development. He was previously at SingVax, in Singapore, as CEO, and Microscience Ltd as Business Development Director. Douglas currently sits on the board of Omideon, a St. Andrews based biotech company focused on the development of novel treatments for cancer. He is also a non-executive director at EnteroBiotix, a microbiome therapeutics platform and product company. Outside-company appointments in this source summarize published experience; no additional current external employer, directorship or personal investment check is inferred.